Cargando…
A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment
With approximately one million diagnosed cases and over 700,000 deaths recorded annually, gastric cancer (GC) is the third most common cause of cancer-related deaths worldwide. GC is a heterogeneous tumor. Thus, optimal management requires biomarkers of prognosis, treatment selection, and treatment...
Autores principales: | Duda, Dan, Dima, Simona, Sorop, Andrei, Kitahara, Shuji, Setia, Namrata, Chivu-Economescu, Mihaela, Matei, Lilia, Herlea, Vlad, Pechianu, Nicolae, Inomata, Takenori, Matsui, Aya, Khachatryan, Anna, Aoki, Shuichi, Lauwers, Gregory, Popescu, Irinel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418549/ https://www.ncbi.nlm.nih.gov/pubmed/37577519 http://dx.doi.org/10.21203/rs.3.rs-3089359/v1 |
Ejemplares similares
-
Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics Analysis as Hub Genes Involved in Gastric Cancer Progression and Prognosis
por: Chivu-Economescu, Mihaela, et al.
Publicado: (2022) -
Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients
por: Duda, Dan G., et al.
Publicado: (2020) -
High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients
por: Necula, Laura, et al.
Publicado: (2020) -
Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening
por: Sorop, Andrei, et al.
Publicado: (2020) -
Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients
por: Mjelle, Robin, et al.
Publicado: (2019)